Abionyx Pharma SA (ABNX) — Capital Reinvestment Ratio

Latest as of December 2022: 0.27x

Abionyx Pharma SA (ABNX) has a Capital Reinvestment Ratio of 0.27x as of December 2022, meaning it reinvests 0% of its operating cash flow (€214.00K) in capital expenditures (€57.00K). See Abionyx Pharma SA (ABNX) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.27x

Capex / Operating Cash Flow

Operating Cash Flow

€214.00K

EUR

Capital Expenditures

€57.00K

EUR

Data as of

Dec 2022

Most recent filing

Annual Capital Reinvestment Ratio for Abionyx Pharma SA (None–None)

Year-by-year Capital Reinvestment Ratio for Abionyx Pharma SA from None to None. For live market cap and broader valuation context, see market value of Abionyx Pharma SA.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow